Basilea Pharmaceutica AG
BPMUF
$71.00
-$0.60-0.84%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -52.75% | -53.53% | -16.46% | -25.89% | 368.03% |
| Total Depreciation and Amortization | 11.53% | 9.71% | 30.87% | 16.14% | 12.06% |
| Total Amortization of Deferred Charges | 3.24% | 1.46% | 8.70% | -3.57% | -86.82% |
| Total Other Non-Cash Items | 170.82% | 169.66% | 170.47% | 162.52% | -427.02% |
| Change in Net Operating Assets | 7,711.57% | 7,588.86% | -111.05% | -109.80% | -98.55% |
| Cash from Operations | -23.98% | -25.22% | 41.04% | 25.13% | 846.96% |
| Capital Expenditure | -103.31% | -100.00% | 24.63% | 33.17% | -151.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -465.45% | -454.17% | -92.49% | -70.63% | 79.98% |
| Cash from Investing | -111.56% | -108.09% | -273.87% | -254.25% | -98.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | 25.85% | 25.85% | -78.08% | -78.08% | -85.96% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4,124.85% | -4,124.85% | -10,219.59% | -10,219.59% | 55.99% |
| Cash from Financing | -34,722.40% | -34,129.92% | -20.70% | -7.09% | 99.94% |
| Foreign Exchange rate Adjustments | 72.02% | 72.43% | -111.11% | -109.79% | 57.20% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -40.91% | -41.87% | 73.78% | 54.18% | 214.23% |